All attending UK organisations

UK companies attending Bio-Europe 2014 as part of the official delegation

(Click here to search profiles):

UK stand (booth #34)
Absynth, Appleyard Lees, Atlantic Healthcare, Autifony, BIA (UK BioIndustry Association), Bionow, Cambridge Bioscience, Canbex Therapeutics, Centre for Pharmaceutical Engineering Science, Chiltern, Clinical Network Services (UK), Crescendo Biologics, Critical Pharmaceuticals, Datatrial, Entrepreneurs Fund, Ex Scientia, Fusion Antibodies, Glythera, Illetrop, KWS BioTest, Moredun Scientific, Novozymes Biopharma, One Nucleus, Phynova, Providion, Quay Pharmaceuticals, Randox Laboratories, Selcia

UK Exhibitors
BioPartner, UK stand #34, Cobra Biologics #53, Fujifilm Diosynth #7, Pharmaceutical Licensing Group #66, Global Data #67

Other UK companies associated with the delegation:
Actigen, Aggio Partners, Cambridge Innovation Capital, cddi, Domainex, Entrepreneurs Fund, Horizon Discovery, HLS (Huntingdon Life Sciences), Immupharma, Isogenica, Koi Consulting, Liftstream, Osborne Clarke, PharmaVentures, Present Value, Proimmune, ProPharma Partners, Sareum, Shionogi, Silicon Valley Bank, Sygnature Discovery, Theradex, UCB Celltech, Virttu Biologics

All attending UK companies:

3M Healthcare Ltd, Abingworth, Absynth Biologics, Actigen, ADC Therapeutics, Aggio Partners Limited, Alacrita LLP, Allergan, Amdipharm Mercury Company, Antitope Ltd, Apex Healthcare Consulting Limited, Apitope, Appleyard Lees, Ario Pharma Ltd, Astex Pharmaceuticals, AstraZeneca, Atlantic Healthcare, Autifony, Avillion LLP , BDO LLP, BIA, BioAscent Discovery Ltd, Bionow, BioOutsource Ltd., BioPartner, BioPharm Insight, Biopharma Technology Ltd, BioProcess International , BRISTOWS LLP, BTG plc, Calcico Therapeutics, Cambridge Bioscience, Cambridge Innovation Capital, Canbex Therapeutics, Cancer Research Technology, Cancer Research UK, Celerion Inc. , Cello Health Consulting, Centre for Pharmaceutical Engineering Science, Charles River, Chiltern, CibaGen Ltd, Citeline, CLINICAL ACCELERATOR, Clinical Network Services (UK) Ltd, Clinigen GAP, Cmed Clinical Services, Cobra Biologics, Competitive Drug Development International Ltd, Coulter Partners, Covington & Burling LLP, Crescendo Biologics Ltd, Critical Pharmaceuticals, Current Partnering, Datamonitor Healthcare Consulting, Datatrial, Decision Resources Group, Domainex Ltd, Durbin PLC, EBR, Edinburgh BioQuarter, Egamid Ltd, Eli Lilly and Company, EMBL-EBI, Entrepreneurs Fund, Epidarex Capital, ERA Consulting UK Ltd, Ergomed plc, Evaluate Ltd, Ex Scientia, Fast Track Pharma Limited, Ferghana Partners, Fidelity Biosciences, FinVector Vision Therapies Ltd, FranceMed Pharma, F-star Biotechnology Ltd, FTS Bio, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, Galen Ltd, Gilead Sciences, Gill Jennings & Every LLP, GlaxoSmithKline, GLG, Global Voices, GlobalData, Glythera, Guidepoint Global, Haemostatix Ltd, Haseltine Lake LLP, HC Pharma Consultancy Ltd, Heptares Therapeutics Ltd, HLS (Huntingdon Life Sciences), Horizon Discovery, ICT Biosciences, Illetrop Ltd, Imanova Limited, Immupharma, Infinata / BioPharm Insight, Informa, Instinctif Partners , Isis Innovation Limited, Isogenica Ltd, JGSbiopharma Ltd, Karus Therapeutics Ltd, KK BIO CONSULTING, Koi Consulting, KWS BioTest, Kymab Ltd, Liftstream, Longcross Advisers LLP, Martindale Pharma, Medius Associates, Mergermarket Group, Merrill DataSite, Midatech, Moredun Scientific, MorEx Development Partners LLP, MorEx Development Partners LLP, MRC TECHNOLOGY LTD, Mundipharma International Ltd., Napp Pharmaceutical Holdings Ltd, Nature Publishing Group, NeRRe Therapeutics Ltd, Newcastle University, Norgine, Norgine Ventures, Novozymes Biopharma UK Ltd, OBN (UK) Ltd, One Nucleus, ONO Pharma UK, Osborne Clarke, Oxford BioMedica, Oxford Biotherapeutics, Oxford Pharmascience Group Plc, Patheon Inc, PGXIS Ltd, Pharmaceutical Licensing Group, Pharmalicensing, PharmaVentures, PharmaVentures, PharmaWave, Phynova, Polytherics Ltd, Premier Research, Present Value, ProFactor Pharma Ltd, Proimmune, Promimme, ProPharma Partners Limited, ProStrakan Group plc, Providion, Proximagen, PsiOxus Therapeutics Ltd, Quay Pharma, Queens University Belfast - Research and Enterprise, Quintiles Limited, R&D Focus Drug News, Randox Laboratories, Redx Pharma, RM Adams & Assoc Ltd , Talentmark and Industrifonden, Rosetta Capital Ltd, Sage Group, Samedan Ltd, Saretius, Sareum, Scottish Development International, Selcia, Shionogi, Sigma-Tau Pharma Limited, Silicon Valley Bank, Silicon Valley Bank, Sitanunga, SmartAnalyst,  Strathclyde University, Sygnature, TauRx Pharmaceuticals Ltd., Taylor Wessing LLP, Teijin Pharma Ltd, The Institute of Cancer Research, Theradex, Therakind Ltd, Thomson Reuters, Torreya Partners, UCB, Unguis Medical (spin-out from The Linde Group), University of Dundee - Drug Discovery Unit , UNIVERSITY OF EDINBURGH - COMMERCIALISATION, Vectura Group plc, Virttu Biologics, Visium Asset Management, Warwick Ventures Ltd, Xention Limited, Xstalbio-Bluegreen (195).

Join them here!